{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:22:20Z","timestamp":1793215340508,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54GM115516"],"award-info":[{"award-number":["U54GM115516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.rpth.2023.100038","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T20:42:15Z","timestamp":1673296935000},"page":"100038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Implementing guidelines to prevent cancer associated thrombosis: how can we do better?"],"prefix":"10.1016","volume":"7","author":[{"given":"Steven","family":"Ades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris E.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100038_bib1","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/onco.13596","article-title":"Update on guidelines for the management of cancer-associated thrombosis","volume":"26","author":"Streiff","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.rpth.2023.100038_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.rpth.2023.100038_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100038_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(93)92244-N","article-title":"Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations","volume":"342","author":"Grimshaw","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.rpth.2023.100038_bib5","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1200\/JOP.19.00697","article-title":"Successful model for guideline implementation to prevent cancer-associated thrombosis: venous thromboembolism prevention in the ambulatory cancer clinic","volume":"16","author":"Holmes","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.rpth.2023.100038_bib7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/rth2.12431","article-title":"Preventing venous thromboembolism in oncology practice: use of risk assessment and anticoagulation prophylaxis","volume":"4","author":"Martin","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100038_bib8","article-title":"Oncologists' attitudes towards prophylaxis of cancer associated venous thromboembolism: a prospective, descriptive study","author":"Kandemir","year":"2021","journal-title":"J\u00a0Oncol Pharm Pract"},{"key":"10.1016\/j.rpth.2023.100038_bib9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/jth.14564","article-title":"The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory patients with cancer: Guidance from the SSC of the ISTH","volume":"17","author":"Wang","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100038_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2023.100038_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100038_bib12","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and\u00a0prophylaxis of venous thromboembolism in patients with cancer,\u00a0including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpth.2023.100038_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12094-019-02263-z","article-title":"SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)","volume":"22","author":"Munoz Martin","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.rpth.2023.100038_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s40199-019-00292-1","article-title":"The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran","volume":"27","author":"Amirsadri","year":"2019","journal-title":"Daru"},{"key":"10.1016\/j.rpth.2023.100038_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40261-019-00876-4","article-title":"A\u00a0Caprini risk score-based cost-effectiveness analysis of enoxaparin for the thromboprophylaxis of patients after nonorthopedic surgery in a Chinese healthcare setting","volume":"40","author":"Bao","year":"2020","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.rpth.2023.100038_bib16","doi-asserted-by":"crossref","first-page":"E1551","DOI":"10.1503\/cmaj.210523","article-title":"Cost-utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer","volume":"193","author":"Kimpton","year":"2021","journal-title":"CMAJ"},{"key":"10.1016\/j.rpth.2023.100038_bib17","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1200\/OP.20.00783","article-title":"Cost-effectiveness of venous thromboembolism prophylaxis during neoadjuvant chemotherapy for ovarian cancer","volume":"17","author":"Ryan","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.rpth.2023.100038_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020367","article-title":"Primary thromboprophylaxis in ambulatory patients with cancer: where do we stand?","volume":"12","author":"Mulder","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.rpth.2023.100038_bib19","first-page":"173","article-title":"Building a CAT clinic - real-world systems approaches to prevention and treatment","volume":"208","author":"Angelini","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100038_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.thromres.2015.08.002","article-title":"Implementation and validation of a\u00a0risk stratification method at The Ottawa Hospital to guide thromboprophylaxis in ambulatory patients with cancer at intermediate-high risk for venous thrombosis","volume":"136","author":"Lustig","year":"2015","journal-title":"Thromb Res"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:22:30Z","timestamp":1762863750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923000031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2475037923000031"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100038","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing guidelines to prevent cancer associated thrombosis: how can we do better?","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100038"}}